GV 2023 GP, L.L.C. — SEC Form 4 filings
SEC reporting owner CIK 1961991. 1 Form 4 filing on record with FilingPulse; latest filed 2025-07-28.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2025-07-28 to 2025-07-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) | 10% owner | 1 | — | — | 3 |
Form 4 filings — GV 2023 GP, L.L.C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-07-28 | 4 | Verve Therapeutics, Inc. (VERV) jointly with GV 2017 GP, L.L.C., GV 2017 GP, L.P., GV 2017, L.P., GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2023 GP, L.P., GV 2023, L.P., Alphabet Inc. | Code (U): 6,108,442 · Code (U): 4,260,047 · Code (U): 1,800,000 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1961991 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →